Safemedex

Tenvir‑FM Tablet, based on authoritative and recent sources in India:

What is Tenvir‑FM?

• Tenvir‑FM is a fixed‑dose antiretroviral combination of:

  • Tenofovir disoproxil fumarate 300 mg

  • Emtricitabine 200 mg

• Marketed by Cipla, this is the generic equivalent of Truvada/ Tenvir‑EM. It is used for:

  • Treatment of HIV‑1 infection, as part of combination antiretroviral therapy

  • Pre‑Exposure Prophylaxis (PrEP) in HIV‑negative individuals at high risk

Tenvir‑EM Tablet (Cipla), based on trusted medical sources in India:

 What is Tenvir ‑EM?

Tenvir‑EM Tablet, marketed by Cipla Ltd, is a fixed‑dose antiretroviral medication combining:

• Emtricitabine 200 mg

• Tenofovir Disoproxil Fumarate 300 mg
  
  

It is the generic equivalent of Truvada and used for both HIV‑1 treatment and pre‑exposure prophylaxis (PrEP) in HIV-negative individuals at risk.

Therapeutic Uses

• Treatment of HIV‑1 infection in combination regimens—helps reduce viral load and preserve immune function.

• Pre‑Exposure Prophylaxis (PrEP): Daily use significantly lowers HIV transmission risk, especially when taken consistently with safe practices.

Efavirenz lamivudine tenofovir disoproxil fumarate tablets are an antiretroviral medication to treat HIV. HIV is a virus that attacks your immune system. This drug works by slowing down how quickly HIV spreads. It doesn't cure HIV or prevent you from spreading it to other people.

Ricovir EM Tablet, based on authoritative sources relevant to India and global guidelines:

 What is Ricovir EM?

• Ricovir EM Tablet is a fixed‑dose antiretroviral medication containing:

  • Emtricitabine 200 mg

  • Tenofovir Disoproxil Fumarate 300 mg

• Manufactured by Mylan Pharmaceuticals (Viatris) in India.

• It’s a generic form of the well-known combination Truvada, used both for HIV‑1 treatment and pre‑exposure prophylaxis (PrEP)

Tenof EM Tablet is a prescription antiretroviral medication manufactured by Hetero (and marketed under Genix/Hetero) that combines:

• Tenofovir Disoproxil Fumarate 300 mg

• Emtricitabine 200 mg
  
  

Therapeutic Uses

• Treatment of HIV‑1 infection, as part of a multi‑drug antiretroviral regimen.

• Pre‑Exposure Prophylaxis (PrEP) to reduce the risk of HIV‑1 acquisition in high-risk, HIV-negative individuals.